Capacity Expansions and Strategic Collaborations Drive Significant Growth in the Global Cell and Gene Therapy Manufacturing Services Market
The global market for cell and gene therapy manufacturing services was estimated to be $4.9 billion in 2022 and is expected to increase to $11.8 billion by 2028, growing at a CAGR of 15.7%.
The cell and gene therapy manufacturing services market is segmented based on application, type, disease, end user, and region. The scope of this study encompasses an investigation of cell and gene therapy manufacturing services.
Cell and gene therapies (CGT) are a novel therapeutic modality for a range of chronic and age-related conditions.
According to the Alliance for Regenerative Medicine 2022 report, CGT research raised nearly $19.9 billion in 2020, $22.7 billion in 2021 and $6.3 billion in the first half of 2022 (H1 2022) and overall investment of $12.6 billion. The number of clinical trials and regulatory approvals for cell and gene therapies will increase over the coming years. The FDA estimates that by 2025, it will approve 10-20 cell and gene therapy products per year, and it is forecasted that by 2030 there will be around 75 approved therapies.
https://finance.yahoo.com/news/capacity-expansions-strategic-collaborations-drive-120300740.html
ارسال به دوستان